CXCL8 and neoplasm: In addition, the improved survival of patients with IL-8 increase compared to the no-change group, which could indicate beneficial immunological responses [38] or immunogenic cell death [25] of tumor cells in a subset of these patients who are actually responding to the treatment, calls for further studies.